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Reporting the Impact of Inferior Vena Cava Perforation By Filters
E.A. Wood, R.D. Malgor, A.P. Gasparis, N. Labropoulos, Stony Brook
University Medical Center, Stony Brook, NY
Background: Perforation of the inferior vena cava (IVC) and its
surrounding structures by filter struts is a known complication. The goal of
our review is to gauge the impact of IVC perforation by filters based on a
‘real world’ open database provided by users, facilities and manufacturers.
Methods:We reviewed 3,123 adverse events of IVC filters reported in
the Food and Drug Administration MAUDE (Manufacturer and User
Facility Device Experience) database from January 2000 to June 2011.
Outcomes of interest were incidence of IVC perforation, type of filter,
clinical presentation, and management of the perforation, including irre-
trievability rates.
Results: Three hundred sixty-seven cases of IVC perforation (12%)
were reported. The annual distribution of IVC perforation was 32 (11%)
cases, varying from 7 (6%) to 70 (17%). A three-fold increase in the number
of adverse events related to IVC filters has been noted since 2004; however,
the accrual numbers of IVC perforation have not significantly changed over
the years (Graph 1). The most common IVC filter involved in IVC perfora-
tion was the Bard G2 Filter Platform System (225, 61%), followed by the
Cook Celect in 38 cases (10%). Vein wall perforation as an incidental finding
was themost common presentation described in 171 (47%) patients. Surround-
ing organ involvement was found in 121 (33%) cases, with the aorta involved in
40 (33%) and the duodenum in 26 (21%) cases. The filter retrieval rate was 84%
regardless of vein wall perforation. Forty (11%) cases required an open proce-
dure to remove the filter due to either multi-organ involvement or a failed
attempt at retrieval. Neither major bleeding requiring further intervention nor
mortality was reported secondary to filter retrieval.
Conclusions: IVC perforations by filters remain stable over the past
decade despite increasing numbers of adverse events reported. The majority
of filters involved in perforation were retrievable and had a multi-prong
design for better attachment to the vein wall. Endovascular filter retrieval,
regardless of IVC wall perforation, is feasible and must be attempted as it is
associated with a higher success rate, and no mortality or major bleeding
events have been reported.
Factors Increasing Risk of Venous Thromboembolism After Arterial
Reconstructive Procedures
L. Mureebe, M. Ghandi, C.K. Shortell, Duke University Medical Center,
Durham, NC
Background: Although the incidence of venous thromboembolic
events (VTE) after common vascular surgical procedures repair is low, we
hypothesize that the risk of VTE may be higher in an identifiable subset of
patients. These patients may benefit from appropriate measures to prevent
VTE. To date, no study has examined and/or elucidated this issue.
Methods: The National Inpatient Survey (NIS) database from years
2000-2009 was reviewed. Records of patients who underwent open repair of
an intact abdominal aortic aneurysm (AAA), carotid endarterectomy (CEA)
aortobifemoral bypass for occlusive disease (ABF) and infrainguinal bypass
(BPG) were crossed with appropriate diagnoses for those operations. The
outcome variable evaluated was the development of VTE (deep vein throm-
bosis (DVT) or pulmonary embolism (PE)) as specified by the International
Classification of Diseases, 9th revision (ICD-9; DVT 453.4 and PE acute
and postoperative 415.19and 415.11, respectively). Perioperative and hos-
pital complications were grouped into five families (intestinal, pulmonary,
urinary, infectious and cardiac). Prior patient histories of VTE and a history
of coagulopathy were also examined. Multivariate analysis of common
complications and the association of these complications with the frequency
of VTE were conducted. Chi-squared statistics were calculated. For all
analyses, p  .05 was considered significant.
Results:The total number of discharges containing one of the procedures
of interest was 750,659. Table I details the number of discharges and the
incidence of VTE for each of the procedures. All the complications we assessed,
except for cardiac, weremore associated with patients who developed VTE. For
all procedures, the combined end point of VTE was statistically more likely in
patients with pulmonary, urinary, infectious complications or had a history of
VTE or a history of coagulopathy. For all procedures, cardiac complication did
not show an associationwith the development of VTE. Intestinal complications
were associated with VTE development in patients undergoing AAA or fem-
distal bypasses, but not CEA or ABF.
Conclusions: The overall rate of VTE in patients undergoing common
vascular surgical procedures is quite low. We have a difference in VTE risk
based on complications that occur during the hospital stay. The observation
of the low incidence of VTE in patients with cardiac complications may be
due to anticoagulation of patients with cardiac complications. This data
suggests we should consider anticoagulation in patients with multiple peri-
operative complications.
Table I. Frequency of procedures and percentage with VTE
Diagnosis n %VTE
AAA 73,545 0.34
CEA 373,465 0.06
ABF 50,415 0.27
BPG 253,234 0.31
Strategy of Thrombus Removal For Extensive DVT of Pregnancy
S. Herrera, S. Thakur, S. Sunderji, R. DiSalle, S.N. Kazanjian, Z. Assi, A.J.
Comerota, The Toledo Hospital, Toledo, Ohio
Background:Extensive deep vein thrombosis (DVT) is associated with
severe postthrombotic morbidity when treated with anticoagulation alone.
Extensive DVT during pregnancy is usually treated with anticoagulation
alone, risking significant postthrombotic morbidity. Thrombolytic therapy
and operative venous thrombectomy have been safely and effectively used in
selected pregnant patients. The purpose of this report is to review the short
and long-term outcomes of eleven patients with extensive DVT of preg-
nancy treated with a strategy of thrombus removal.
Methods: From 1999-2011, eleven patients were referred for manage-
ment of extensive DVT during pregnancy, ten patients with iliofemoral/
caval DVT and one with acute superior vena caval syndrome. Gestational age
ranged from 8 to 36 weeks. All patients were offered a strategy of thrombus
removal including catheter-directed thrombolysis, pharmacomechanical
thrombolysis (PMT), and/or operative venous thrombectomy. Fetal mon-
itoring was performed throughout hospitalization. Radiation exposure was
minimized by using pelvic lead shields, limiting fluoroscopy, using small
visual fields, hand held contrast injections and avoiding magnified views.
Following intervention, leg compression was applied, patients were antico-
agulated with heparin and ambulated. Patients were converted to vitamin K
antagonists after delivery. Follow up included objective evaluation using
venous duplex and the Villalta scale.
Results: Catheter-directed thrombolysis and PMT were used in nine
patients. Two patients declined thrombolytic therapy but agreed to venous
thrombectomy, and one patient had operative thrombectomy as an adjunct
to PMT. Each patient had complete or near complete thrombus resolution
and rapid improvement in clinical symptoms. Eight patients delivered
healthy infants at term; two are currently in their third trimester, one
suffered an in-utero death 5 days post lysis due to her antiphospholipid
antibody syndrome. One patient developed two major complications, gross
hematuria requiring blood transfusion and a left popliteal artery pseudoan-
eurysm that resolved with compression ultrasound. Mean follow up was 2
years, without evidence of recurrence. Three patients had uneventful subse-
quent pregnancies. Venous duplex ultrasonography demonstrated patent
veins and normal valve function in 8 patients. Of the 10 patients with
iliofemoral DVT, 9 had Villalta scores4, and one patient had a score of 5,
consistent with mild postthrombotic syndrome.
Conclusions:Extensive DVT of pregnancy can be effectively and safely
treated with a strategy of thrombus removal, resulting in a patent venous
systemwith normal valve function, prevention of postthrombotic morbidity,
and reduction in recurrence. Operative and catheter-based techniques can
be tailored to the patient.
Value of Postoperative Compression After Surgical Treatment of Var-
icose Veins
P. Pittaluga, S. Chastanet, Riviera Veine Institut, Nice, France
Fig.
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 1 Abstracts 301
